<p>Background mortality probabilities were derived from the national age-specific mortality rates for Malaysia, adjusted for the degree of excess non-liver-related mortality calculated from persons diagnosed HCV Ab+ in Scotland (1991–2005), in which the window of 6 months subsequent to HCV diagnosis date is excluded from follow-up time to reduce bias associated with testing individuals presenting with disease.</p><p>Progression probabilities for transitions between disease progression model states, and corresponding prior distributions.</p
<p>Annually, women move between health stages according to defined transition rates given in <a href...
Cardiovascular Diseases (CVDs) are the number one cause of deaths worldwide and management of these ...
<p>(A) Risk of progression at a time step of 1.5 years given no progression at earlier time steps (<...
<p>The duration of each stage is indicated (if temporary) together with the probability of transitio...
The prevalence of hepatitis C virus (HCV) infection in Malaysia has been estimated at 2.5% of the ad...
The Markov process is a useful tool for modeling the natural history of disease, which is becoming i...
Multistate models can be successfully used for describing complex event history data, for example, d...
<p>HCV: hepatitis C virus.</p><p>HCC: hepatocellular carcinoma.</p>#<p>In the prevalence a clearance...
Probabilities of disease-stage transition, according to National Alzheimer’s Coordinating Centre dat...
<p>(A) The estimated rates of progression of infection with HPV-16, HPV-18 and other high-risk (OHR)...
A better understanding of disease progression is beneficial for early diagnosis and appro-priate ind...
The article of record as published may be found at http://dx.doi.org/10.1002/sim.5808Markov models o...
<p>Evolution of follow-up HCV testing rates, of HCV diagnosis rates and of HCV infection rates (per ...
<p>Probabilities of progression to CKD stage 5 in the next t years after inclusion into the cohort f...
The analysis of cause of death is increasingly becoming a topic in oncology. It is usually distingui...
<p>Annually, women move between health stages according to defined transition rates given in <a href...
Cardiovascular Diseases (CVDs) are the number one cause of deaths worldwide and management of these ...
<p>(A) Risk of progression at a time step of 1.5 years given no progression at earlier time steps (<...
<p>The duration of each stage is indicated (if temporary) together with the probability of transitio...
The prevalence of hepatitis C virus (HCV) infection in Malaysia has been estimated at 2.5% of the ad...
The Markov process is a useful tool for modeling the natural history of disease, which is becoming i...
Multistate models can be successfully used for describing complex event history data, for example, d...
<p>HCV: hepatitis C virus.</p><p>HCC: hepatocellular carcinoma.</p>#<p>In the prevalence a clearance...
Probabilities of disease-stage transition, according to National Alzheimer’s Coordinating Centre dat...
<p>(A) The estimated rates of progression of infection with HPV-16, HPV-18 and other high-risk (OHR)...
A better understanding of disease progression is beneficial for early diagnosis and appro-priate ind...
The article of record as published may be found at http://dx.doi.org/10.1002/sim.5808Markov models o...
<p>Evolution of follow-up HCV testing rates, of HCV diagnosis rates and of HCV infection rates (per ...
<p>Probabilities of progression to CKD stage 5 in the next t years after inclusion into the cohort f...
The analysis of cause of death is increasingly becoming a topic in oncology. It is usually distingui...
<p>Annually, women move between health stages according to defined transition rates given in <a href...
Cardiovascular Diseases (CVDs) are the number one cause of deaths worldwide and management of these ...
<p>(A) Risk of progression at a time step of 1.5 years given no progression at earlier time steps (<...